We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Endo lifted its stay of litigation against the FDA and is going ahead with a lawsuit challenging the agency’s policy on bulk drug compounding. Read More
Westminster Pharmaceuticals recalled two of its thyroid drugs after manufacturing them with APIs sourced from a Chinese supplier the FDA cited for GMP violations. Read More
Merck and GlaxoSmithKline called for more information from the FDA in comments on the agency’s draft guidance for sponsors using the limited population pathway for antibacterial and antifungal drugs (LPAD). Read More
Purdue Pharma violated a 2015 agreement with New York by deceptively marketing opioids, including Oxycontin, New York Attorney General Barbara Underwood alleges in a new lawsuit. Read More
Ohio will require pharmacy benefit managers (PBM) contracting with its Medicaid program to end their current “spread pricing” arrangements and shift to a more transparent pricing model on Jan. 1. Read More
The U.S. Court of Appeals said AHF could not demonstrate any connection to the intellectual property that gave it standing for a patent case. Read More